RYTM
Rhythm Pharmaceuticals Inc
98.30$
+0.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 92.9% | 92.6% | 91.1% | 93.6% | 93.6% | 95.4% | 95.5% | 96.8% | 97.6% | 97.2% | 97.2% | 97.6% | |
| 18.2% | 18.1% | 20.7% | 42.3% | 13.1% | 22.7% | 27.4% | 36.4% | 10.3% | 11.3% | 14.0% | 15.0% | |
| 84.5% | 82.9% | 77.8% | 83.6% | 82.1% | 81.7% | 81.3% | 78.1% | 82.1% | 81.0% | 77.0% | 75.7% | |
| 4.1% | 4.5% | 5.7% | 4.6% | 5.3% | 4.7% | 4.6% | 7.0% | 6.5% | 5.4% | 7.7% | 9.2% | |
| 2.2% | 2.6% | 3.3% | 3.1% | 3.8% | 4.8% | 5.0% | 5.1% | 4.4% | 5.4% | 6.5% | 7.0% | |
| 2.0% | 2.1% | 2.6% | 1.7% | 1.8% | 1.6% | 1.5% | 1.5% | 1.1% | 1.1% | 1.2% | 1.1% | |
| 44.2% | 49.0% | 76.2% | 53.0% | 58.0% | 58.1% | 57.8% | 64.2% | 41.7% | 43.8% | 46.3% | 50.3% | |
| 14.2% | 16.6% | 20.9% | 14.3% | 26.8% | 29.4% | 28.9% | 34.7% | 20.6% | 22.1% | 23.3% | 28.3% | |
| 0.2% | 0.2% | 0.3% | 0.2% | – | – | 0.1% | 0.1% | 0.1% | 0.1% | 0.2% | 0.2% | |
| 1.1% | 1.5% | 2.9% | 1.2% | 1.3% | 3.1% | 3.1% | 4.3% | 2.7% | 2.9% | 2.8% | 3.7% | |
| 55.8% | 51.0% | 23.8% | 47.0% | 42.0% | 41.9% | 42.2% | 35.8% | 58.3% | 56.2% | 53.7% | 49.7% | |
| -240.9% | -268.9% | -400.6% | -279.8% | -305.9% | -294.5% | -311.6% | -335.8% | -257.3% | -281.5% | -318.2% | -333.2% | |
| 16.3% | 17.8% | 23.3% | 16.0% | 16.8% | 15.7% | 16.3% | 17.1% | 12.7% | 13.9% | 15.4% | 15.7% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.